New antimicrobial bioactivity against multidrugresistant gram-positive bacteria of kinase inhibitor imd0354

Medicine & Life Sciences

• N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide 100%
• Gram-Positive Bacteria 56%
• Vancomycin 43%
• Phosphotransferases 39%
• 5-chloro-2-hydroxybenzamide 24%
• NF-kappa B 21%
• Caenorhabditis 17%
• Bacteria 13%
• Staphylococcal Infections 11%
• Methicillin-Resistant Staphylococcus aureus 10%
• Biofilms 10%
• Lead 9%
• Staphylococcus aureus 8%
• Poisons 7%
• Anti-Bacterial Agents 6%
• Membranes 6%
• Survival 5%
• Health 5%
• Infections 4%
• Pharmaceutical Preparations 4%
• Therapeutics 1%

Chemistry

• Phosphotransferase Inhibitor 64%
• Bioactivity 36%
• Antimicrobial Agent 35%
• Bacteriostatic 34%
• Vancomycin 32%
• Inhibitory Concentration 32%
• Biofilm Formation 32%
• Haemolytic 29%
• Minimum Inhibitory Concentration 28%
• Toxic 19%
• Strain 17%
• Drug 13%